AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $111 | -68.4% | 12,166 | -75.2% | 0.00% | – |
| Q4 2022 | $351 | -100.0% | 49,096 | -66.1% | 0.00% | -100.0% |
| Q3 2022 | $726,000 | +109.2% | 144,957 | +1.7% | 0.00% | – |
| Q2 2022 | $347,000 | -65.2% | 142,577 | -2.4% | 0.00% | -100.0% |
| Q1 2022 | $998,000 | -21.6% | 146,142 | -7.3% | 0.00% | 0.0% |
| Q4 2021 | $1,273,000 | +121.8% | 157,637 | +168.7% | 0.00% | 0.0% |
| Q3 2021 | $574,000 | +144.3% | 58,672 | +67.8% | 0.00% | – |
| Q2 2021 | $235,000 | -25.6% | 34,970 | 0.0% | 0.00% | – |
| Q1 2021 | $316,000 | +58.8% | 34,970 | +17.1% | 0.00% | – |
| Q4 2020 | $199,000 | +4875.0% | 29,860 | +4876.7% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | 0.0% | 600 | +50.0% | 0.00% | – |
| Q3 2017 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |